Oncology Archives - Page 10 of 23

Real-world burden of adverse events for apalutamide- or enzalutamide-treated non-metastatic castration-resistant prostate cancer patients in the United States

Authors: A Hussain, S Jiang, D Varghese, S Appukkuttan, N Kebede, K Gnanasakthy, C Macahilig, R Waldeck, S Corman Published: BMC cancer, 2022 View publication Background Second-generation androgen receptor inhibitors (ARIs) have...

Real-world comparison of healthcare resource utilization and costs of [177 Lu]Lu-DOTA-TATE in patients with progressive neuroendocrine tumors in England: a matched cohort analysis using data from the hospital episode statistics dataset

Authors: T Cox, M O'Connell, O Leeuwenkamp, S Palimaka, N Reed Published: Current medical research and opinion, 2022 View publication Objective To explore the healthcare resource utilization (HCRU) and costs for patients...

Real-world cost-effectiveness of primary prophylaxis with G-CSF biosimilars in patients at intermediate/high risk of febrile neutropenia

Authors: P Cornes, J Kelton, R Liu, O Zaidi, J Stephens, J Yang Published: Future oncology (London, England), 2022 View publication Background Real-world data suggests superiority of pegfilgrastim (PEG) over filgrastim (FIL)...

Renal function changes and NHS resource use in breast cancer patients with metastatic bone disease treated with IV zoledronic acid or oral ibandronic acid: A four-centre non-interventional study

Authors: S Houston, R J Grieve, T Hickish, F Percival, E Hamilton Published: Journal of Medical Economics, 2010 View publication Aims To describe renal function monitoring practice in patients with metastatic bone...

Systematic literature review of current treatments for stage I-III Merkel cell carcinoma

Authors: R Palencia, A Sandhu, S Webb, T Blaikie, M Bharmal Published: Future oncology (London, England), 2021 View publication Aim There is a need to evaluate current treatments for stages I-III of...

The burden of managing pleural effusions in patients with chronic myelogenous leukemia post-imatinib failure: A literature-based economic analysis

Authors: J Stephens, K T Carpiuc, M Botteman Published: International Journal of General Medicine, 2010 View publication Objectives To develop an economic analysis of the management of pleural effusions in patients with...

Conceptual assessment of HRQOL among Japanese non-metastatic castration-resistant prostate cancer (nmCRPC) patients

Authors: K Nishimura, M Shiota, M Eto, T Satoh, A Stroupe, C Seo, A Uzumcu, D A Ledesma Published: Cancer medicine, 2022 View publication Objective The study objectives were to understand how...

Treatment patterns and real-world clinical outcomes in patients with advanced endometrial cancer that are non-microsatellite instability high (non-MSI-high) or mismatch repair proficient (pMMR) in the United States

Authors: S S Kelkar, V S Prabhu, J Zhang, S Corman, C Macahilig, N Rusibamayila, S Odak, L R Duska Published: Gynecologic oncology reports, 2022 View publication Objective Microsatellite instability (MSI) due...

Systematic literature review of trials assessing recommended systemic treatments in hepatocellular carcinoma

Authors: S Ronnebaum, A Aly, D Patel, F Benavente, J-D Rueda Published: Hepatic Oncology, 2021 View publication Aim To identify and evaluate the similarity of all trials assessing recommended treatments for advanced...

News